Category: Pharma, Life Sciences & Med Tech Players
-
EWHC hinders Accordâs plans to launch Entresto competing product in Novartis patent dispute
Mr. Justice Meade of the High Court of Justice for England & Wales has held that all of Accordâs âattacksâ on a Novartis Entresto patent have failed, and its own intended competing product would infringe the defendantâs supplementary protection certificate.
-
UPC Munich LD flags novel questions on damages law in Edwards v. Meril damages claim, flags novel questions on applicable law and non-infringing substitute profits
At an interim hearing, the Munich LD set Edwardsâ damages claim against Meril at a âŹ15 million value in dispute and previewed how it may rule on two open legal questions.
-
Patent Litigation Europe returns for 2027, building on last year’s rebrand into three co-located tracksÂ
Speakers already confirmed for the event include Hon. Emmanuel Gouge and AleĆĄ Zalar of the UPC, Judge Oliver Schön of the Munich Regional Court, Abbottâs Gael Tisack, Ericssonâs Gabriele Mohsler, Nokiaâs Clemens Heusch, and SIM IPâs Erich Spangenberg.
-
Chinaâs top court hands U.S. patentee landmark patent damages award
U.S. insecticide producer FMC Agriculture Singapore has been awarded a record of nearly 33 million Chinese yuan ($4.84 million) in patent infringement damages in a decision in which the defendantâs legal representative has also been found jointly liable â a rarity in Chinese IP infringement cases.
-
U.S. GLP-1 patent docket grows with raft of new complaints from Eli Lilly, Novo Nordisk
This could well be the start of a wide-ranging, multi-jurisdictional campaign by Eli Lilly to defend its rights around Mounjaro and Zepbound.
-
10x Genomics accused of infringing sequencing patents by Caltech and exclusive licensee
10x is no stranger to enforcing its own sequencing patents, but Spatial Genomics’ District of Delaware complaint sees it on the receiving end of an infringement claim.
-
UPC keeps Merz infringement case despite earlier French filing
The UPCâs Paris LD rejected Viatrisâ attempt to halt Merzâs infringement action in favor of parallel proceedings before a French national court. The ruling clarifies when earlier national proceedings prevent the UPC from continuing with an infringement action.
-
âThe future of medicine and diagnosticsâ: behind the patent enforcement strategy of biotech tools company SeerÂ
Seerâs VP of Legal, George Fox, discusses the challenges that its patent portfolio has recently overcome, and the enforcement campaign it has launched in the U.S.Â
-
Malikie Innovations sets sights on medical device segment with latest U.S. complaint targeting Abbott
The heir to the BlackBerry patent portfolio appears to be testing the waters in the multibillion-dollar market for connected medical devices.
-
Moderna calls itself the âtrue innovatorâ in response to CureVac mRNA patent lawsuit, cites broken non-assert promise
Moderna has filed a response to CureVacâs mRNA patent suit, denying infringement, attacking the validity of all 10 patents, and calling the lawsuit âultimately a meritless attempt to claim success for work it never didâ.